Gossamer Bio (GOSS) Debt/EBITDA US GAAP (year values) |
||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | |||
| Debt/EBITDA | 0.67 | 0.14 | 0.52 | 2.29 | -0.40 | -0.61 | ||
| Changes by years, y/y, % | -54% | -79% | +266% | +342% | -117% | |||
Gossamer Bio. Debt/EBITDA
Gossamer Bio. Debt/EBITDA, changes, %
Gossamer Bio (GOSS) Debt/EBITDA US GAAP (quarter values) |
||||||||
| FY2025Q1 | FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | LTM ? | |||
| Debt/EBITDA | 1.54 | 0.08 | -0.16 | -0.41 | -0.61 | -0.61 | ||
| Changes by years, y/y, % | +578% | -97% | -107% | -118% | -140% | |||
| Changes by quarters, q/q, % | -33% | -95% | -298% | +164% | +49% | |||